| OUT-LICENSING / TECHNOLOGY TRANSFER |
| INN |
Indication |
Dosage Form |
Status |
| Propofol |
Aneasthetics? |
Injectable emulsion |
CTD dossier,? API self-produced |
| Fat Emulsion |
TPN |
Injectable emulsion |
CTD dossier available |
| Fulvestrant |
Metastatic breast cancer |
IV Injection |
IND in the USA; PCT; self-produced API |
| Ropivacaine Sustained-release |
Analgesia |
Subcutaneous Injection? |
IND in the USA;? Independent intellectual property; self-produced API |
| Ropinirole HCl |
Parkinson's disease |
Extended Release Tablet |
CTD dossier available, self-produced API |
| Bosentan |
Pulmonary artery hypertension (PAH) |
Tablet |
Lab-scale, self-produced API |
| Solifenacin succinate |
Urge urinary incontinence |
Tablet |
Lab-scale, self-produced API |
| Melphalan HCl |
Multiple myeloma and ovarian cancer |
Injection |
Formulation process under development,? API |